Alongside Claude Sonnet 5, Anthropic shipped a second, quieter announcement today that may matter more for where the company is heading: Claude Science, a beta “AI workbench” aimed squarely at working scientists. It runs on macOS and Linux — locally or against a remote HPC cluster over SSH — and it’s available now to Pro, Max, Team, and Enterprise users.
The framing is that research is fragmented across a dozen disconnected tools, and Claude Science collapses them into one environment that carries a project from literature review through compute jobs to a publication-ready figure. That’s a familiar pitch. What makes this one worth attention is that a frontier lab is no longer selling a general model and hoping scientists wire it up themselves. It’s selling the wiring.
What’s Actually in the Box
Three pieces do the real work.
Domain skills and connectors. Claude Science ships with 60-plus curated skills and connectors pre-configured for genomics, single-cell analysis, proteomics, structural biology, and cheminformatics, with direct access to the reference databases researchers actually live in — UniProt, PDB, Ensembl, Reactome, ClinVar, ChEMBL, GEO. It integrates NVIDIA’s BioNeMo models, including Evo 2, Boltz-2, and OpenFold3. This is the part that’s hard to replicate with a chat box and a few prompts: someone has already done the integration labor for an entire scientific discipline.
Compute orchestration. The workbench handles job setup, submission, and scaling on its own — single GPU to hundreds — and runs that work on the lab’s own infrastructure, whether that’s a laptop, an HPC cluster, or Modal on-demand capacity. Sensitive data stays on local systems rather than being shipped to a vendor. For research groups bound by data-governance rules around patient or genomic data, “it runs where your data already is” is not a footnote; it’s the precondition for using the thing at all.
Rich scientific artifacts. It natively renders 3D protein structures, genome-browser tracks, and chemical structures, and it generates figures and manuscripts with the underlying code, message history, and environment captured for reproducibility. A built-in reviewer agent checks citations and calculations before the work leaves your hands.
The Validation Claims Are the Interesting Part
The launch leans on user stories, and the numbers in them are large enough to be worth scrutiny rather than applause.
Jérôme Lecoq at the Allen Institute built a multi-agent computational review template out of roughly 20 custom skills, and reports collapsing literature reviews that previously took two years. Stephen Francis at UCSF’s Brain Tumor Center describes glioma epidemiology analysis running in “roughly one-tenth the time it previously took.” Manifold Bio frames it as doing tissue-targeting drug work “end-to-end, gathering the right data and applying the right judgment.”
Read those carefully and the same word keeps appearing: validation. Lecoq’s pitch is AI-checked citations, not unsupervised review. Francis stresses “independent validation” alongside the tenfold speedup. The reviewer agent exists precisely because a model that fabricates a plausible citation or quietly drops a unit conversion is worse than no tool at all in a domain where the output ends up in a paper. The honest version of this product isn’t “the AI does your research.” It’s “the AI does the mechanical 90% and a human still owns the judgment and the sign-off.” The labs getting the tenfold numbers are the ones that built that discipline into the workflow, not the ones that trusted the first draft.
A Frontier Lab Goes Vertical
Strip away the biology and a strategic pattern is visible. Anthropic is taking the same stack it has been productizing all year — a capable model, plus a library of domain skills, plus connectors, plus the compute to run it — and pointing it at a specific high-value vertical with the integration work pre-done.
That’s the same architecture as Claude for Small Business, just aimed at a structural biologist instead of a bookkeeper. The bet underneath both is identical: the model is increasingly a commodity, and the durable value is in the domain-specific skills, the sanctioned connectors, and the responsibility for the workflow actually working. It fits the broader 2026 thesis we’ve tracked of the frontier splitting into gated specialists — generic capability is cheap and everywhere, so the labs are racing to own the vertical-specific layer on top.
It also extends Anthropic’s partner-network strategy in a telling direction. The BioNeMo integration means Anthropic isn’t trying to out-model the specialist scientific-ML shops; it’s orchestrating them. Claude Science is positioned as the conductor that calls Evo 2 or OpenFold3 when the task demands it, not a replacement for them.
The Grant Program Is Customer Acquisition
Anthropic paired the launch with an AI for Science program: up to 50 projects receive $30,000 in credits each, with Modal adding up to $2,000 of compute per selected project. Applications close July 15, and funded projects run September 1 through December 1.
Read it for what it is. This is a beta product that needs real research workloads to harden its 60 skills against the messy edge cases of actual lab data, and a sales motion that needs reference customers in genomics and structural biology. Subsidizing 50 labs to push the tool through three months of real work buys Anthropic both — case studies and battle-testing — far more efficiently than a marketing campaign would. That’s not a criticism; it’s a sensible way to launch a vertical product into a skeptical, credentialed audience. It does mean the most polished success stories six months from now will be the ones Anthropic paid to seed, and they should be read with that in mind.
What to Watch
For research groups, the questions that decide whether this is a tool or a demo are concrete. Does it run cleanly against your cluster’s scheduler, or only the happy-path configurations? Do the 60 skills cover your subfield or stop at the well-funded ones? And does the reviewer agent actually catch the errors that matter — the dropped covariate, the wrong reference genome build — or only the easy ones?
The macOS-and-Linux, HPC-aware, data-stays-local design says Anthropic understands the constraints real labs operate under, which is more than most “AI for science” launches manage. Whether the skills are deep enough to survive contact with a working research group is what the next three months of funded projects will reveal. A workbench is only as good as its least reliable tool, and in science the cost of the unreliable one isn’t a bad answer — it’s a retraction.
